These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
198 related articles for article (PubMed ID: 29283339)
1. KAI1/CD82, Metastasis Suppressor Gene as a Therapeutic Target for Non-Small-Cell Lung Carcinoma. Prabhu VV; Devaraj SN J Environ Pathol Toxicol Oncol; 2017; 36(3):269-275. PubMed ID: 29283339 [TBL] [Abstract][Full Text] [Related]
2. KAI1/CD82, a tumor metastasis suppressor. Liu WM; Zhang XA Cancer Lett; 2006 Aug; 240(2):183-94. PubMed ID: 16260083 [TBL] [Abstract][Full Text] [Related]
3. Evaluation of the correlation of vasculogenic mimicry, Notch4, DLL4, and KAI1/CD82 in the prediction of metastasis and prognosis in non-small cell lung cancer. Wang Y; Yang R; Wang X; Ci H; Zhou L; Zhu B; Wu S; Wang D Medicine (Baltimore); 2018 Dec; 97(52):e13817. PubMed ID: 30593175 [TBL] [Abstract][Full Text] [Related]
4. [Expression of CD82/KAI1 and HIF-1α in non-small cell lung cancer and their relationship to vasculogenic mimicry]. Wu S; Cheng Z; Yu L; Song W; Tao Y Zhongguo Fei Ai Za Zhi; 2011 Dec; 14(12):918-25. PubMed ID: 22152691 [TBL] [Abstract][Full Text] [Related]
5. Expression and clinical significance of CD82/KAI1 and E-cadherin in non-small cell lung cancer. Shiwu WU; Lan Y; Wenqing S; Lei Z; Yisheng T Arch Iran Med; 2012 Nov; 15(11):707-12. PubMed ID: 23102249 [TBL] [Abstract][Full Text] [Related]
6. KAI1/CD82 expression in nonsmall cell lung carcinoma is a novel, favorable prognostic factor: an immunohistochemical analysis. Higashiyama M; Kodama K; Yokouchi H; Takami K; Adachi M; Taki T; Ishiguro S; Nakamori S; Yoshie O; Miyake M Cancer; 1998 Aug; 83(3):466-74. PubMed ID: 9690539 [TBL] [Abstract][Full Text] [Related]
7. Adenoviral transduction of MRP-1/CD9 and KAI1/CD82 inhibits lymph node metastasis in orthotopic lung cancer model. Takeda T; Hattori N; Tokuhara T; Nishimura Y; Yokoyama M; Miyake M Cancer Res; 2007 Feb; 67(4):1744-9. PubMed ID: 17308116 [TBL] [Abstract][Full Text] [Related]
8. Correlation of KAI1/CD82 gene expression with good prognosis in patients with non-small cell lung cancer. Adachi M; Taki T; Ieki Y; Huang CL; Higashiyama M; Miyake M Cancer Res; 1996 Apr; 56(8):1751-5. PubMed ID: 8620488 [TBL] [Abstract][Full Text] [Related]
9. Effect of KAI1/CD82 on the beta1 integrin maturation in highly migratory carcinoma cells. Jee BK; Lee JY; Lim Y; Lee KH; Jo YH Biochem Biophys Res Commun; 2007 Aug; 359(3):703-8. PubMed ID: 17560548 [TBL] [Abstract][Full Text] [Related]
10. KAI1/CD82 Genetically Engineered Endothelial Progenitor Cells Inhibit Metastasis of Human Nasopharyngeal Carcinoma in a Mouse Model. Wang G; Zhang L; Zhou Y; Sun Q; Xu H; Cai F; Xiang P; Chen Z; Jiang H Med Sci Monit; 2018 May; 24():3146-3152. PubMed ID: 29755107 [TBL] [Abstract][Full Text] [Related]
11. KAI1/CD82 decreases Rac1 expression and cell proliferation through PI3K/Akt/mTOR pathway in H1299 lung carcinoma cells. Choi UJ; Jee BK; Lim Y; Lee KH Cell Biochem Funct; 2009 Jan; 27(1):40-7. PubMed ID: 19107873 [TBL] [Abstract][Full Text] [Related]
12. KAI1/CD82 suppresses tumor invasion by MMP9 inactivation via TIMP1 up-regulation in the H1299 human lung carcinoma cell line. Jee BK; Park KM; Surendran S; Lee WK; Han CW; Kim YS; Lim Y Biochem Biophys Res Commun; 2006 Apr; 342(2):655-61. PubMed ID: 16488391 [TBL] [Abstract][Full Text] [Related]
13. Down-regulation of the metastasis suppressor protein KAI1/CD82 correlates with occurrence of metastasis, prognosis and presence of HPV DNA in human penile squamous cell carcinoma. Protzel C; Kakies C; Kleist B; Poetsch M; Giebel J Virchows Arch; 2008 Apr; 452(4):369-75. PubMed ID: 18305955 [TBL] [Abstract][Full Text] [Related]
14. Expression and clinical significance of p53, JunB and KAI1/CD82 in human hepatocellular carcinoma. Guo C; Liu QG; Zhang L; Song T; Yang X Hepatobiliary Pancreat Dis Int; 2009 Aug; 8(4):389-96. PubMed ID: 19666408 [TBL] [Abstract][Full Text] [Related]
15. [Relationship between the levels of KAI1/CD82 and CD44 and the clinicopathological features of non-small cell lung cancer]. Chen QY; Lin XM; Zhou JY; An Z; Yang L; Jiang ZY Zhonghua Jie He He Hu Xi Za Zhi; 2004 Feb; 27(2):101-4. PubMed ID: 14990184 [TBL] [Abstract][Full Text] [Related]
16. Decreased expression of KAI1/CD82 metastasis suppressor gene is associated with loss of heterozygosity in melanoma cell lines. Kim YI; Shin MK; Lee JW; Chung JH; Lee MH Oncol Rep; 2009 Jan; 21(1):159-64. PubMed ID: 19082457 [TBL] [Abstract][Full Text] [Related]
17. Gene expression analysis of human prostate cell lines with and without tumor metastasis suppressor CD82. Dodla P; Bhoopalan V; Khoo SK; Miranti C; Sridhar S BMC Cancer; 2020 Dec; 20(1):1211. PubMed ID: 33298014 [TBL] [Abstract][Full Text] [Related]
18. The palmitoylation of metastasis suppressor KAI1/CD82 is important for its motility- and invasiveness-inhibitory activity. Zhou B; Liu L; Reddivari M; Zhang XA Cancer Res; 2004 Oct; 64(20):7455-63. PubMed ID: 15492270 [TBL] [Abstract][Full Text] [Related]
19. Metastasis suppressor KAI1/CD82 attenuates the matrix adhesion of human prostate cancer cells by suppressing fibronectin expression and β1 integrin activation. Lee HA; Park I; Byun HJ; Jeoung D; Kim YM; Lee H Cell Physiol Biochem; 2011; 27(5):575-86. PubMed ID: 21691075 [TBL] [Abstract][Full Text] [Related]
20. Nuclear factor-kappaB-dependent expression of metastasis suppressor KAI1/CD82 gene in lung cancer cell lines expressing mutant p53. Shinohara T; Miki T; Nishimura N; Nokihara H; Hamada H; Mukaida N; Sone S Cancer Res; 2001 Jan; 61(2):673-8. PubMed ID: 11212267 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]